New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
February 24, 2014
06:41 EDTWLP, CI, WCG, HNT, UAM, HUM, AET, UNHMedicare Advantage proposal worse than bear case, says Leerink
Leerink says CMS late Friday disclosed the 2015 Advance Rate Notice for Medicare Advantage with an all-in rate of down 7.25%. The firm notes the rate is incrementally worse than its bear case expectation of down 7%. Leerink believes the advance rate notice has the most downside impact on 2015 earnings for Humana (HUM), WellCare (WCG), UnitedHealth (UNH) and Universal American (UAM), and it points out that Cigna (CI), Aetna (AET), Health Net (HNT) and WellPoint (WLP) are also exposed.
News For HUM;WCG;UNH;UAM;CI;AET;HNT;WLP From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | all recent news | >>
March 27, 2015
16:12 EDTHNTHealth Net receives contract extension for TRICARE program
Subscribe for More Information
March 25, 2015
10:00 EDTUNHOn The Fly: Analyst Initiation Summary
Subscribe for More Information
07:38 EDTUNH, CI, AETPrice targets raised for Managed Care Organizations at UBS
UBS raised its price targets on the Managed Care Organizations in their coverage universe. The firm cites increased volumes, a lack of new legislation, the potential for industry consolidation, and limited exposure to international markets that face a weak macro economic backdrop. UBS raised its price target on Aetna (AET) to $128 from $120, Anthem (ANTM) to $175 from $163, Cigna (CI) to $149 from $140 and United Health (UNH) to $135 from $131. UBS has a Buy rating on all four stocks.
07:05 EDTUNHUnitedHealth initiated with a Buy at Mizuho
Subscribe for More Information
March 24, 2015
08:49 EDTHUMHumana price target raised to $193 from $167 at Oppenheimer
Oppenheimer increased its price target on Humana (HUM) to reflect the company's sale of Concentra to Select Medical (SEM) and Welsh Carson for $1.055B. The firm says that the deal is likely to be supportive of Humana's earnings growth over the longer term. It keeps an Outperform rating on the shares.
07:43 EDTHUMDaVita subpoenas have mixed outcomes, says William Blair
Subscribe for More Information
07:41 EDTHUMHumana received DOJ request for information on Medicare
Subscribe for More Information
06:12 EDTWCGWellCare says Chairman David Gallitano will not stand for re-election
Subscribe for More Information
March 23, 2015
12:17 EDTHUMOn The Fly: Midday Wrap
Subscribe for More Information
09:07 EDTHUMSelect Medical agrees to acquire Concentra through JV with Welsh Carson
Subscribe for More Information
09:04 EDTHUMHumana to sell Concentra to Select Medical, Welsh Carson for $1.055B in cash
Humana (HUM) has reached a definitive agreement to sell the stock of its wholly-owned subsidiary, Concentra, to MJ Acquisition Corporation, a joint venture between Select Medical Holdings Corporation (SEM), an operator of specialty hospitals and outpatient rehabilitation clinics in the U.S., and Welsh, Carson, Anderson & Stowe XII, L.P., a private equity fund, for approximately $1.055B in cash, subject to customary adjustments. Humana acquired Concentra in December 2010. Subsequently, the assets of certain privately-operated Community Based Outpatient Clinics were transferred into Concentra. Additionally, Humana has divested certain Concentra non-core assets over the past four years. The decision to divest Concentra demonstrates the company’s commitment to its previously announced business portfolio review. Humana will continue performing its review of the alignment and return potential of businesses across the organization to ensure each supports the company’s integrated care delivery strategy and earns the appropriate return on invested capital. The Concentra transaction is anticipated to close during the second quarter of 2015 subject to Hart Scott Rodino regulatory clearance and customary closing conditions. Humana anticipates using the net proceeds from the transaction to advance its strategic growth priorities, to fund additional share repurchases under its existing $2 billion authorization and for general corporate purposes. Goldman, Sachs & Co. is acting as financial advisor to Humana. Fried, Frank, Harris, Shriver & Jacobson LLP is acting as legal advisor to Humana. Concentra reported revenues for the year ended December 31, 2014 were approximately $1B. Humana anticipates the Concentra divestiture will be slightly dilutive to 2015 EPS excluding any one-time gain expected upon the close of the transaction.
09:02 EDTHUMHumana reiterates FY15 EPS view $8.50-$9.00, concensus $8.87
Subscribe for More Information
09:02 EDTHUMHumana to sell Concentra to Select Medical, Welsh Carson for $1.055B in cash
March 20, 2015
08:18 EDTUNH, WCG, CI, UAM, HNT, HUM, AETLeerink healthcare services analyst holds an analyst/industry conference call
Healthcare Services Analyst Gupte discusses Sustainable Growth Rate (SGR) and the proposed pay-fors and implications For Healthcare Services on an Analyst/Industry conference call to be held on March 20 at 11 am.
March 19, 2015
10:12 EDTHNTHealth Net to reaffirm FY15 EPS guidance 'at least' $2.70
Subscribe for More Information
10:02 EDTAETOn The Fly: Analyst Upgrade Summary
Subscribe for More Information
08:20 EDTAETAetna upgraded at Sterne Agee
As noted earlier, Sterne Agee upgraded Aetna to Buy from Neutral. The firm says that the company is the best-positioned name within the large-cap health plan space , a defensive sector that has little exposure to Europe and reasonable growth prospects, according to the firm.
06:19 EDTAETAetna upgraded to Buy from Neutral at Sterne Agee
Subscribe for More Information
March 18, 2015
12:46 EDTAETAetna, HackensackAlliance ACO announce collaboration
Subscribe for More Information
March 17, 2015
09:00 EDTAETAetna management to meet with JPMorgan
Subscribe for More Information
1 | 2 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use